Clinical Trials Logo

Clinical Trial Summary

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.


Clinical Trial Description

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bwtween the 2 indicies, as well as with EMG, Concentration of Propofol (CeP) and Remifentanil (CeR) during Total Intravenous Anesthesia with Target Controlled Infusion (TIVA-TCI). ;


Study Design


NCT number NCT06349681
Study type Observational
Source University of Padova
Contact Federico Linassi, MD
Phone 0422322440
Email federico.linassi@gmail.com
Status Recruiting
Phase
Start date April 1, 2024
Completion date October 1, 2024